Product Information
FLUTICASONE PROP 50 MCG SPRAY is a generic product labeled by Advagen Pharma Ltd., priced at $0.4451 per GM under NDC 72888014135. Its NADAC has been published 60 times since Aug 13, 2025.
FDA first approved this application on Jun 5, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 ug/1
Manufacturer
Advagen Pharma Ltd.NDC
72888014135
Classification
Generic
Dosage Form
SPRAY
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
FLUTICASONE PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA218321FDA Approved
6/5/2025
TE Code
AB
On Market Since
6/5/2025
Pharmacological Classes
Price Statistics
The NADAC for FLUTICASONE PROP 50 MCG SPRAY has been published 60 times since Aug 13, 2025, and over the history we have for it it has declined 2.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4451 per GM |
|---|---|
| All-time high | $0.4560 (Sep 10, 2025) |
| All-time low | $0.4413 (May 20, 2026) |
| 52-week high | $0.4512 |
| 52-week low | $0.4413 |
| Median price | $0.4473 |
| Average price | $0.4473 |
| Largest weekly change | -1.5% (Sep 17, 2025) |
| Weeks tracked | 60 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the FLUTICASONE PROPIONATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FLUTICASONE PROPIONATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUTICASONE PROP 50 MCG SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for FLUTICASONE PROP 50 MCG SPRAY, manufactured by Advagen Pharma Ltd., is $0.4451 per GM (NDC 72888014135), effective Sep 30, 2026.
How has the price of FLUTICASONE PROP 50 MCG SPRAY changed over time?
Over the history we have for it, the NADAC for FLUTICASONE PROP 50 MCG SPRAY has declined 2.3%. It has been tracked across 60 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for FLUTICASONE PROP 50 MCG SPRAY?
Since Aug 13, 2025, the NADAC for FLUTICASONE PROP 50 MCG SPRAY has ranged from a low of $0.4413 (May 20, 2026) to a high of $0.4560 (Sep 10, 2025), with a median of $0.4473 per GM.
Are there cheaper alternatives to FLUTICASONE PROP 50 MCG SPRAY?
No other NADAC-published product currently shares the active ingredient and strength of FLUTICASONE PROP 50 MCG SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLUTICASONE PROP 50 MCG SPRAY?
FLUTICASONE PROP 50 MCG SPRAY (NDC 72888014135) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.